A novel approach for longitudinal analysis of serum biomarkers of joint metabolism and knee injury in military officers
These exploratory analyses suggest that CPII alone, or in combination with other joint metabolism biomarkers, may help identify individual risk of knee injury.
Authors
- V. B. Kraus
- J. S. Marron
- Q. Fu (ORCID: https://orcid.org/0000-0002-4249-8287)
- Travis C. Burns (ORCID: https://orcid.org/0000-0001-8356-9793)
- L. Callahan
- Maryalice Nocera
- Liubov Arbeeva
- Jesse R. Trump
- Yvonne M. Golightly
- Stephen W. Marshall
Institutions
- University of North Carolina at Chapel Hill (US)
- Nebraska Medical Center (US)
- Duke University (US)
- Keller Army Community Hospital (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1371/journal.pone.0341836
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hospital for Special Surgery
- Novo Nordisk
- National Institutes of Health
- University of North Carolina at Chapel Hill
- National Institute of Arthritis and Musculoskeletal and Skin Diseases